I fully understand it's painful to see for those from higher price buy-ins, but this is not IMO toxic financing; it's rather expensive interim money, which admittedly I hadn't planned on to incur six months ago. However, our prospect now for financing is 180 degrees to the positive from back then because of the acquisition(s) and potential of the business model, and the quality of financing agents working with us.
With my being the largest SMKY shareholder with the same class of common stock as you, I assure you there will not be what could be considered [real] toxic financing that funds SMKY; I see it coming in within a range that makes it a fair value structure at minimum to potential for a great appreciation of our equity upon conversions of the combination of PS and convertible debt being offered. I will not accept financing that inhibits our ability to grow market value via operating success, and a toxic transaction is one that creates a 100 to 200 million share overhang if we took in $15 million or more and had to give say a .25 conversion price because of our current market.
And, for those posters not grasping why financing would come to us, there are three aspects to understand: 1) the acquisition(s) make SMKY instantly profitable with at least $30+ million revenue; 2) SMKY's wholesale and retail pricing of its products drops so substantially via the processor acquisition and our business model that we will have the highest quality at the lowest pricing on the market to drive sales in all market sectors; and 3) our Kosher market potential, deals in Canada, and the added up-side of BarBQ Diner give us massive revenue scale and EPS capabilities. The Business/Acquisition Financing Plan is available for shareholders to review upon request.
